Clinical Trials on Hydatidiform Mole in New Zealand
Total 2024 results
-
Memorial Sloan Kettering Cancer CenterAureon Biosciences, Inc.; NYU MEDICAL CENTERCompleted
-
Herbert Irving Comprehensive Cancer CenterUnknownProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Eli Lilly and CompanyBayerActive, not recruitingProstatic NeoplasmsSpain, Germany, United States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedProstate Cancer | OsteoporosisUnited States
-
Bristol-Myers SquibbAstellas Pharma Inc; Clovis Oncology, Inc.Active, not recruitingProstate CancerUnited States, Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Mexico, Spain
-
University of FloridaPatient-Centered Outcomes Research InstituteActive, not recruitingProstate CancerUnited States
-
National Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Adenocarcinoma of the Gastroesophageal Junction | Recurrent Breast Cancer | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Mount Sinai Hospital, CanadaMcGill University; Canadian Institutes of Health Research (CIHR); Weill Medical... and other collaboratorsUnknownNon-obstructive AzoospermiaUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Herbert Irving Comprehensive Cancer CenterUnknownProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
AstraZenecaNot yet recruitingHepatocellular Carcinoma | Prostate CancerUnited States
-
DisperSol Technologies, LLCTranslational Drug DevelopmentActive, not recruiting
-
Taiho Oncology, Inc.Active, not recruitingMetastatic Castration Resistant Prostate CancerFrance, United States, Spain, United Kingdom
-
University of Texas Southwestern Medical CenterBoston Scientific CorporationActive, not recruitingProstate Cancer AdenocarcinomaUnited States
-
Novo Nordisk A/STerminated
-
Daniel George, MDJanssen Scientific Affairs, LLCActive, not recruiting
-
Thomas Jefferson UniversityProstate Cancer FoundationActive, not recruitingBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Memorial Sloan Kettering Cancer CenterFordham UniversityCompleted
-
The University of QueenslandThe HOME Network; Australia and New Zealand Dialysis and Transplant Registry; New Zealand Peritoneal Dialysis RegistryActive, not recruitingKidney Disease, Chronic | Peritoneal Dialysis Catheter Exit Site Infection | Peritoneal Dialysis Catheter-Associated Peritonitis | Peritoneal Dialysis Catheter Tunnel InfectionAustralia, New Zealand
-
Aderans Research InstituteCompletedAndrogenetic Alopecia | Male Pattern Baldness | Female Pattern BaldnessUnited States
-
Novo Nordisk A/SCompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United States, United Kingdom, New Zealand, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedStage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | PSA Level Five to Ten | PSA Level Less Than Five | PSA Level Ten to FiftyUnited States
-
BayerCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
Merus N.V.RecruitingMetastatic Castration-resistant Prostate Cancer | NSCLC Harboring NRG1 FusionUnited States
-
Columbia UniversityRecruitingStress | Sleep | Suicide | Mental Health Wellness 1 | Nurse's Role | Work Environment Adverse EffectsUnited States
-
Royal North Shore HospitalWithdrawn
-
BioProtectCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Columbia UniversityWithdrawnProstate Cancer | Robotic Prostatectomy | Foley Catheter DiscomfortUnited States
-
AstraZenecaCompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Stony Brook UniversityProgenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Royal North Shore HospitalCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States
-
Astellas Pharma IncAgensys, Inc.CompletedProstate CancerUnited States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompleted
-
Department of Veterans Affairs, New JerseyPfizerUnknownA Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerProstate CancerUnited States
-
Department of Veterans Affairs, New JerseySanofi; PfizerUnknownProstate CancerUnited States
-
VA Office of Research and DevelopmentActive, not recruitingProstate CancerUnited States